Skip to main content

Featured

Market Jitters Return as Cooler CPI Surprises Wall Street

A softer‑than‑expected U.S. Consumer Price Index reading sent a ripple through financial markets today, creating an unusual dynamic: good news on inflation, but renewed pressure on major stock indexes. A Cooling CPI, but a Nervous Market The latest CPI report showed inflation easing more than economists anticipated. Under normal circumstances, that would be a welcome sign—suggesting the Federal Reserve may have more room to consider rate cuts later in the year. But markets don’t always behave logically in the moment. Today, the S&P 500, Dow Jones Industrial Average, and Nasdaq all slipped as investors reassessed what the data means for corporate earnings, interest‑rate expectations, and the broader economic outlook. Why Stocks Reacted This Way Several factors contributed to the pullback: Profit‑taking after recent market highs Concerns that cooling inflation reflects slowing demand Uncertainty about the Fed’s next move , even with softer price pressures Sector rotation ...

article

Cancer-Causing Chemical Detected in Acne Treatments: Brands Under Scrutiny

 


In a recent alarming discovery, independent U.S. laboratory Valisure has detected high levels of the cancer-causing chemical benzene in certain acne treatments. Brands affected include:

  1. Clinique (Estee Lauder)
  2. Clearasil (Reckitt Benckiser-owned)
  3. Proactiv
  4. Target Corp.'s Up & Up
  5. PanOxyl
  6. Walgreens’ acne soap bar
  7. Walmart’s Equate Beauty acne cream

Benzene, a known carcinogen, was found not only in the acne products themselves but also in the air around incubated products, suggesting a potential inhalation risk. Valisure has filed a petition with the U.S. Food and Drug Administration (FDA) urging product recalls, investigations, and revised industry guidance. The situation is substantially different from previous cases where benzene impurities came from contaminated ingredients. Here, benzene originates directly from the benzoyl peroxide itself, forming at unacceptably high levels.

Consumers are advised to stay informed as regulatory responses unfold. The FDA’s reaction to Valisure’s petition remains pending. Companies implicated in this issue, including Estee Lauder, have yet to respond to media inquiries.

As we await further developments, it’s crucial to prioritize safety and informed choices when it comes to skincare products. 









Comments